Baillie Gifford & Co’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-115
| Closed | -$4.61K | – | 409 |
|
|
2023
Q1 | $4.61K | Hold |
115
| – | – | ﹤0.01% | 419 |
|
|
2022
Q4 | $5.33K | Hold |
115
| – | – | ﹤0.01% | 442 |
|
|
2022
Q3 | $5K | Hold |
115
| – | – | ﹤0.01% | 449 |
|
|
2022
Q2 | $7K | Hold |
115
| – | – | ﹤0.01% | 441 |
|
|
2022
Q1 | $8K | Hold |
115
| – | – | ﹤0.01% | 451 |
|
|
2021
Q4 | $10K | Hold |
115
| – | – | ﹤0.01% | 449 |
|
|
2021
Q3 | $10K | Hold |
115
| – | – | ﹤0.01% | 446 |
|
|
2021
Q2 | $11K | Hold |
115
| – | – | ﹤0.01% | 426 |
|
|
2021
Q1 | $13K | Buy |
115
+9
| +8% | +$1.02K | ﹤0.01% | 386 |
|
|
2020
Q4 | $15K | Buy |
+106
| New | +$15K | ﹤0.01% | 351 |
|